This paper is in the following e-collection/theme issue:

Quality Evaluation and Descriptive Analysis/Reviews of Multiple Existing Mobile Apps (362) Mobile Apps for Cancer Care and Cancer Prevention and Screening (197)

Published on in Vol 5, No 3 (2017): March

Content, Usability, and Utilization of Plain Language in Breast Cancer Mobile Phone Apps: A Systematic Analysis

Content, Usability, and Utilization of Plain Language in Breast Cancer Mobile Phone Apps: A Systematic Analysis

Content, Usability, and Utilization of Plain Language in Breast Cancer Mobile Phone Apps: A Systematic Analysis

Authors of this article:

Tamar Ginossar1 Author Orcid Image ;   Sayyed Fawad Ali Shah1 Author Orcid Image ;   Andrew J West1 Author Orcid Image ;   Joshua M Bentley2 Author Orcid Image ;   Charlene A Caburnay3 Author Orcid Image ;   Matthew W Kreuter3 Author Orcid Image ;   Anita Y Kinney4 Author Orcid Image
Article Authors Cited by (37) Tweetations (12) Metrics

    Original Paper

    1Department of Communication and Journalism, University of New Mexico, Albuquerque, NM, United States

    2Department of Strategic Communication, Texas Christian University, Fort Worth, TX, United States

    3Health Communication Research Laboratory, Brown School of Social Work, Washington University in Saint Louis, Saint Louis, MO, United States

    4Department of Internal Medicine, Health Science Center, University of New Mexico, Albuquerque, NM, United States

    Corresponding Author:

    Tamar Ginossar, PhD

    Department of Communication and Journalism

    University of New Mexico

    1 University of New Mexico

    Albuquerque, NM, 87108

    United States

    Phone: 1 5052775305

    Fax:1 5052771902

    Email: ginossar@unm.edu


    Background: Breast cancer is one of the leading contributors to preventable illness and death among women. Although mobile phone apps provide unprecedented opportunity to engage women along the cancer continuum, little is known about the availability, content, and usability of breast cancer mobile phone apps.

    Objective: This study analyzed the content and adherence to literate design standards of all breast cancer-related apps available on the App Store and Google Play, as well as the relationship between their content, user ratings, and price.

    Methods: Following identification and downloading of all available breast cancer mobile phone apps in October 2015, 101 apps were confirmed as focusing on breast cancer. Based on prior research, we adapted and applied a content analysis scheme that was specific to breast cancer apps, including their main purpose, relevance to the cancer care continuum, and adherence to usability standards outlined by the Institute of Medicine (IOM).

    Results: The most common aim of apps was educational (73/101, 72.3%), followed by behavior change (24/101, 23.9%), fundraising (20/101, 19.8%), and advocacy (14/101, 13.9%). On the cancer continuum, primary prevention (strategies to prevent cancer cells from occurring) was mentioned in almost one-third of the apps (30/101, 29.7%). Less than half of the apps (46/101, 45.5%) presented information about mammography and/or breast clinical exam, and 53 apps (52.5%) discussed breast self-exam (which is no longer recommended). Symptoms of cancer prediagnosis, such as a lump, were discussed in almost half of the apps (48/101, 47.5%) and a similar number of apps included information about genetic risk for breast cancer (47/101, 46.5%). Information about breast cancer diagnosis was included in 42 apps (41.58%) and 43 (42.6%) apps discussed treatment options. Survivorship issues were addressed in 17 (16.8%) apps. Only one (1.0%) app discussed hospice. Adherence to usability recommendations was low. The median composite score was 3 (mean 2.60, SD 1.20) of the six recommended usability items. With eight plain language items, the median of the composite health literacy score was 5 (mean 5.06, SD 2.00). Most apps did not use easy-to-understand words (44/101, 43.6%) and few (24/101, 23.8%) defined key terms.

    Conclusions: Current breast cancer apps provide important information about breast cancer, but the most common topic covered is breast self-examination, a non-evidence-based screening strategy. Apps that focus on evidence-based strategies on the cancer continuum are needed, with a notable pressing need for apps that would address survivorship and end of life. Finally, developers of breast cancer apps should adhere to IOM standards to meet the needs of diverse populations and reduce current disparities.

    JMIR Mhealth Uhealth 2017;5(3):e20

    doi:10.2196/mhealth.7073

    Keywords

    mobile phones; mobile apps; breast cancer; cancer-related content 


    Overview, Rationale, and Goals

    More than 1,677,000 women worldwide are diagnosed with breast cancer and more than 522,000 die of it annually [1], making it the most commonly occurring cancer and the principal cause of death from cancer among women globally [2]. Breast cancer constitutes a major contributor to preventable cancer burden [3,4], which refers to the morbidity and mortality that can be reduced by health behavior change, access, and utilization of screening and treatment services. Notably, most of the inequity in cancer health outcomes, including international and interethnic differences in breast cancer incidence and mortality, are attributed to preventable causes [5,6]. Although evidence-based comprehensive programs have documented successes in increasing breast cancer survival rates in high resources settings, much work is needed in increasing their reach, particularly among medically underserved populations in the United States and beyond [7].

    Mobile health technology, or mHealth, holds great potential in reducing disparities in cancer-related health outcomes. With nine of 10 Americans owning at least one cell phone, and a majority (63%) of these devices providing access to mobile Internet service [7], it has tremendous penetration. Unlike previous communication technologies [8], these devices are disproportionally used by members of low-resources communities, with minority users more likely to access the Internet exclusively from their mobile phone [9]. Further, well-designed mHealth holds great potential in promoting health in low-resources communities in developing [10] and developed countries [11]. In view of the international and national burden of breast cancer and the potential of mHealth in improving medical and public health practices [12], it is important to understand the use of breast cancer-related apps across the cancer care continuum. However, although half of cell phone users reported downloading apps in 2013 [13], little is known about these apps’ design, availability, and health-related use in general and in the context of breast cancer in particular. To date, studies have examined content of cancer-related apps using content analysis of apps’ descriptions on the App Store [14], of cancer-related apps available on iPhone only [15], and of studies reporting on educational cancer apps [16], yet the specific content of breast cancer-related apps available to consumers along the cancer care continuum [17] has not been examined. Studies of mHealth reveal that although apps offer beneficial functions [18], consumers are faced with a “bewildering array” of available health apps [19], with varied and often dubious quality [20,21]. Of apps that focus on cancer awareness, few discuss evidence-based preventive health behaviors [14], a deficiency that is likely because of a lack of medical professional involvement in design of apps [22]. Furthermore, cancer-related apps can pose a danger; for instance, skin cancer-related apps accurately assessed melanoma only 10% of the time [23].

    To reach individuals from low-resources communities who are disproportionally affected by preventable cancer burden, literate principles should be followed in the design of apps. The Institute of Medicine (IOM) published guidelines on mHealth-literate design strategies, including plain language and appropriate usability features [24]. However, it is unknown to what degree these standards are implemented in the design of breast cancer-related apps [24].

    In view of the importance of breast cancer as a public health concern, the goal of this study was to systematically analyze the availability and content of breast cancer apps available on the main platforms of Google Play and the App Store, and their main features, including content on the cancer care continuum, goals, adherence to the IOM literacy guidelines, price, and user ratings. The following sections review past research on these factors as they relate to breast cancer mHealth.

    Prevention

    A growing body of evidence documents mHealth interventions’ effectiveness in engaging users in cancer preventive measures [25]. For instance, text message reminders to female patients before scheduled breast cancer screenings were found to greatly increase screening attendance [26]. Apps have also been shown to successfully increase breast cancer screenings in rural areas as well as disseminate important breast cancer information where cultural and social constraints prevent the spread of accurate breast health information [27,28].

    Treatment

    Apps are also utilized to enhance care delivery during cancer treatment. These apps work as information management tools where patients can check appointments, journal symptoms, and log medications [29]. These apps and devices can also reduce the communication gap between patients and providers, expedite treatment, allow patients to more easily report side effects of chemotherapy and other treatments to health care providers in a timely manner [10,30], provide information about postchemotherapy side effect management, and assist cancer patients with medication adherence [11]. Although mHealth has great potential for cancer supportive care during treatment (eg, management of symptoms), research has not explored its role in improving patient quality of life [23,31].

    Survivorship

    Survivorship is another important area for mHealth cancer care interventions. In addition to cancer recurrence, breast cancer survivors are at a greater risk of comorbid conditions, such as obesity, osteoporosis, cardiovascular disease, and diabetes [32], and many breast cancer survivors do not meet healthy lifestyle recommendations [32]. Several mHealth interventions on nutrition quality, physical activity, and improved eating self-efficacy have addressed this problem and were found to facilitate significant short-term weight loss, decrease waist circumference, and increase self-efficacy in breast cancer survivors [33]. It has been suggested that lifestyle interventions for cancer survivors, including breast cancer survivors, should incorporate text messages and mobile phone apps to augment existing survivorship interventions [34]. In addition, researchers noted the potential of apps to increase physical activity for breast cancer survivors [35] and the successful reduction of stress among breast cancer survivors in a technology-based self-management intervention [36] further demonstrates the promise of technology-based survivorship interventions.

    mHealth Literacy

    User skills are key to effective utilization of mHealth, particularly among underserved communities. Digital health literacy is related to one’s ability to seek, locate, comprehend, and assess health information from electronic sources [37]. The concept of digital literacy draws on health literacy, defined as the ability to understand and use health information, communicate needs to health providers, and understand information from health care institutions [38]. Health literacy is strongly related to health outcomes, including cancer communication [39]. Similarly, digital health literacy is related to age and education, as well as to better outcomes as a result of health information seeking [40]. Use of mobile technology is dependent on both health and digital literacy skills. Digital literacy is crucial to engage in health maintenance, change behavior, and utilize health care services [41]. People with low literacy are less likely to access the Internet to seek information about health concerns [20], despite strong information needs following cancer diagnosis [42,43]. Patients with low health literacy are less likely to use health apps or perceive them as easy or useful, and hence are less likely to benefit from this technology [31]. Understanding different literacy levels is consistent with research by Second-Level Digital Divide [36] that examined different skill levels of using digital communication technologies. Health-literate apps can bridge the digital divide by improving quality and usefulness of health information and interventions that would ultimately lead to better health outcomes [24].

    The price of apps is an additional factor in apps’ dissemination and adoption of health promotion messages. Paid diabetes apps demonstrated better adherence to IOM standards compared to free apps [44]. Such advantage of paid apps has the potential to limit the dissemination of health information and to increase health disparities because most users are reluctant to pay for apps [45]. However, it is unknown whether these differences are manifested in apps in other health-related content areas, including breast cancer.

    Finally, although systematic reviews aim at addressing availability and analyzing the content and features of the analyzed apps use [46], mHealth allows some insight into users’ experiences by featuring user ratings of apps. User ratings have been shown to be correlated with professional quality ratings of apps [47]; therefore, exploring their association with adherence to literate app design has the potential to shed light on the relationship between design and user experience.

    In view of the preceding research, the goal of this study is to evaluate the availability and content of existing breast cancer-related apps. In particular, we assessed apps’ content for intended purpose, consistency with the breast cancer care continuum, adherence to IOM plain language and usability standards, and the association between adherence to standards and apps’ prices and users’ reviews.


    Sampling

    The study did not involve recruitment of human population; therefore, ethics committee approval was not required. Following previous content analyses of mHealth apps [44,48], a list of breast cancer apps was generated in October 2015. Apple apps were searched directly from the App Store using an iPad device. Android apps were searched on Google Play Android App Store using an Android tablet device. The “any price” (Apple App Store) and “all price” (Google Play Android App Store) search options were selected to include both free and paid (fee-based) apps in the search results. The search term “breast cancer” on both platforms resulted in 264 unique apps (105 Apple apps, 131 Android apps) and 28 apps that were available on both platforms. Apps were chosen for analysis if they met the following inclusion criteria: (1) English-language app, (2) focused on breast cancer, (3) health related (as opposed to apps that included entertainment only, such as ringtones), and (4) intended for a general audience of consumers rather than health care professionals. A total of 163 apps were excluded (see Figure 1 for information on reasons for exclusion). One app had both a free and an upgraded paid version and the content was found to be different, so both versions were coded. The final sample of apps that were downloaded and coded in this analysis was 101, including 44 unique Android apps, 38 unique Apple apps, and 19 apps that were available on both platforms. Most of the apps were free (85/101, 84.1%) and only a minority (16/101, 14.8%) were paid apps. See Figure 1 for the process of inclusion and exclusions of apps.

    ‎
    Figure 1. App Exclusion Chart.
    View this figure

    Coding Process

    At the time of the study, only one prior study explored content of apps and adherence to IOM standards in diabetes-related apps [44]. Consequently, no coding scheme was available for use in the context of breast cancer. This previous IOM-related coding scheme [44] was applied, and its content-related scheme was adapted to the breast cancer context based on past literature and in particular the focus of this study on the cancer continuum. TG created the initial adaptation based on the literature and her experience as a cancer communication researcher, and three additional authors provided input based on their knowledge and experience in cancer communication, including clinical experience of the last author. Following discussions between the researchers, the coding scheme was finalized (see Table 1 for the coding scheme). Two trained graduate research assistants downloaded each app to an iPad or an Android tablet. After reviewing the app’s features, they entered information into an electronic database. The coding process began with coding general characteristics listed in the App Store and Google Play. Then, coders coded cancer-related content and adherence to the IOM recommendations (see Table 1 for a list of variables) for designing health-literate mobile apps. The coders were trained by TG for two sessions lasting a total of 5 hours and then they coded the apps individually. Two independent coders coded a sample of 30 apps (29.7% of the total sample) to test intercoder reliability. Any coding disagreements were discussed collectively with the first author until agreement was reached. For each variable, intercoder reliability was assessed using Krippondorf alpha (see Table 1).

    Table 1. Variable categories, names, definitions, and intercoder reliabilities.
    Category and nameDefinitionIntercoder reliability, Krippendorf αa
    Purpose


    		Information/educationContent to inform/educate1.0

    		Behavior change/maintenanceContent to motivate, encourage behavior change1.0

    		FundraisingRaising money, donations0.88

    		AdvocacyOther than fundraising0.86
    Cancer continuum primary prevention


    		Primary preventionHealth promotion activities, diet, and exercise1.0
    Genetic risk/screening


    		RiskGenetic risk (eg, BRCA discussed)0.89

    		ScreeningGenetic screening discussed1.0
    Screening evidence-based


    		MammographyMammography discussed0.90
    Non-evidence-based clinical breast examClinical breast exam discussed1.0

    		Breast self-examBreast self-exam discussed1.0
    Symptoms prediagnosisCancer symptoms prediagnosis discussed/explained0.90
    Diagnosis


    		StageCancer stages discussed0.89

    		Tumor typeTypes of tumors discussed0.90

    		PrognosisPrognosis discussed, including survival1.0
    Treatment


    		Treatment optionsBreast cancer treatment discussed1.0

    		Side effects/symptomsTreatment side effects discussed1.0

    		Medication care managementInformation on medication types/brands1.0
    Chemotherapy preventionChemotherapy prevention medication1.0
    SurvivorshipLife after cancer discussedN/A
    End of lifeEnd-of-life/hospice informationN/A
    Breast cancer care


    		Breast cancer continuum careBreast cancer continuum care and or behaviors discussed0.89
    Research/Science

    Biological processInformation on biological process of breast cancer1.0
    Trial recruitmentClinical trial recruitmentN/A
    Research referencedApp cites medical research studies0.74
    Adherence to literate principles design plain language


    		Common, everyday wordsCommon plain language used1.0

    		Personal pronounsPersonal pronouns such as “you” used0.90

    		Defined termsTerms explained/defined1.0

    		Active voiceUse of active voice1.0

    		Action wordsDirect action language used1.0

    		Present tensePresent tense used1.0

    		Short sentencesSentences 15-20 words max1.0

    		Limited paragraph sizeShort paragraphs, use of bullets/lists1.0
    Usability


    		Images for learningUse images that facilitate learning1.0

    		Bold colors/backgroundUse bold colors with contrast; avoid dark backgrounds0.71

    		Home/menu pageEnables easy access to home/menu page0.71

    		Back buttonBack button identified as arrow or labeled0.85

    		Simple searchUtilizes simple search tool0.71

    		BrowsingEasy browsing/navigating through app0.75
    Technology


    		EmailConnected with device email option/in-app email options0.71

    		CalendarConnected with device calendar0.53

    		Reminders/notificationsOffered device notifications0.78

    		Maps/GPSOffered maps/GPS options0.87

    		PrintIncluded print options0.65

    		Save optionsSave content as .doc, PDF, image filesN/A
    Interactivity


    		Personal informationContact information input1.0

    		Personal statisticsInput of height, weight, etc1.0

    		Expert interactionInteractions with medical professionals1.0

    		Peer supportInteraction with other app usersN/A

    		Connect with eventLink user with event source1.0

    		Audio/video featuresUse of sound bite/video content1.0

    		New mediaUse of social media and/or text0.90

    a N/A: Krippendorff alpha could not be calculated due to lack of variance.

    Coding Scheme

    General Characteristics

    Basic information was captured from the App Store and Google Play, such as the provider or seller, price (if any), age rating, app category, and numbers for both ratings and reviews for each coded app and its price.

    Purpose of the App

    For perceived purpose of the app content, coders noted one or more of the following four categories: (1) information/education (eg, reference/glossary of breast cancer terms), (2) behavior change/maintenance (eg, becoming more physically active, participating in screening), (3) fundraising, and (4) advocacy (eg, awareness-raising campaigns).

    Cancer Continuum-Related Content

    To examine the apps’ foci on the cancer care continuum, one or more of the following variables were coded: (1) primary prevention; (2) evidence-based cancer screening (mammography, clinical breast exam); (3) diagnosis, including information about cancer staging, type of tumor, and information about prognosis, such as survival rate; (4) disease management/therapeutics, including information about treatment, side effects of treatments, and treatment medications and chemo prevention to prevent recurrence; (5) survivorship; and (6) end-of-life care. In addition, the following prediagnosis categories were coded: (1) genetic risk (eg, family history of cancer) and (2) breast self-exam and symptoms of breast cancer prediagnosis. Finally, the coding scheme included research and scientific-related content, which was comprised of information on the biological process of cancer, references to research, and discussions of clinical trials.

    Adherence to IOM Literate Design Principles

    To assess the apps’ adherence to the IOM mHealth literacy guidelines [24], we used the coding scheme developed and tested by Caburnay and colleagues [44]. Plain language variables included the presence or absence of the following: (1) common everyday words, (2) the pronoun “you” (second person voice), (3) use of present tense, (4) defined technical terms, (5) use of active voice, (6) use of action words, (7) use of short sentences (15-20 words), and (8) limited paragraph length (including bullet points and short lists). Each of these eight variables was coded (0=not present; 1=present), and the results were summed to create a composite plain language score.

    Usability was measured as a composite of (1) avoidance of dark backgrounds, (2) easy access to home page (eg, home/menu button), (3) clearly labeled back button, (4) in-app simple search, (5) enabled browsing, and (6) use of images that facilitate learning (eg, diagrams of breast anatomy). Each of these six variables was coded (0=not present; 1=present) and summed to create a composite usability score [24,44].

    Variables on graphics and technology use were also recorded and were composed of integration with other device apps (email, calendar, maps, reminders, GPS) and save/print options. Interactivity variables included user-tailored/interactive content (eg, input contact information, measures such as weight and height, expert interactions, online peer support, connect user with event), use of audio and video features, and use of new media or texting (eg, Facebook, Twitter).

    Statistical Analysis

    We used SPSS version 23 (IBM Corp, Armonk, NY, USA) to calculate descriptive statistics; t tests to identify associations between app characteristics, price (free vs paid), and user ratings; and Pearson correlations to examine the relationship between IOM guidelines and user ratings. Significance was determined at a level of alpha=.05.


    Road Map

    Our goal in this study was to better understand availability and content of breast cancer-related apps available to the public, with a focus on their purpose, cancer continuum-related content, adherence to IOM literate design standards, price, and user ratings.

    Sample Description and General Characteristics

    The final sample of apps that met our selection criteria and was used in the final analysis (N=101) included 44 apps (43.7%) that were available on Google Play only, 28 (27.7%) apps that were available exclusively on the App Store, and 19 (18.8%) that were available on both platforms (see Table 2 and Figures 2-5). Most apps were free (85/101, 84.2%). Of the 16 (15.8%) paid apps, prices ranged from US $0.99 to US $4.99 with a mean of US $2.15. User ratings were provided for 49 apps; the median number of ratings per app was 6 (mean 25.16, SD 74.50), and the median star rating was 4.5 of 5 (mean 4.00, SD 1.27). In total, 40 of 101 apps (39.6%) were either rated for all ages or for ages 4 years or older. Another 19 (18.8%) were rated for 12 years and older, and 17 (16.8%) were rated for 17 years and older. The categories in which the apps were placed most often were health and fitness (24.8%, 25/101) and medical (31.7%, 32/101).

    Table 2. Characteristics of breast cancer-related apps on the App Store and Google Play (N=101).
    App characteristicsn (%)
    Type of apps

    		Android44 (43.6)

    		Apple38 (37.6)

    		Android & Apple19 (18.8)

    		Free apps85 (84.1)

    		Paid apps16 (14.8)
    Purpose

    		Information/education73 (72.3)

    		Behavior change/maintenance24 (23.8)

    		Fundraising20 (19.8)

    		Advocacy14 (13.9)
    Cancer continuum

    		Primary prevention


    		Prebiological onset30 (29.7)


    		Genetic risk/screening


    		Risk47 (46.5)


    		Screening29 (28.7)

    		Evidence-based screening


    		Mammography45 (44.6)


    		Clinical exam38 (37.6)

    		Non-evidence-based screening


    		Breast self-exam53 (52.5)


    		Symptoms prediagnosis48 (47.5)

    		Diagnosis


    		Stage30 (29.7)


    		Tumor type35 (34.7)


    		Prognosis19 (18.8)

    		Management/Therapeutics


    		Treatment38 (37.6)


    		Side effects19 (18.8)


    		Care management31 (30.7)

    		Chemotherapy prevention14 (13.9)

    		Survivorship17 (16.8)

    		End of life1 (1.0)
    Research/Science

    		Biological information40 (39.6)

    		Trial recruitment5 (5.0)

    		Research referenced24 (23.8)
    Literate principles adherence

    		Plain language


    		Common everyday words44 (43.6)


    		Personal pronouns60 (59.4)


    		Defined terms24 (23.8)


    		Active voice78 (77.2)


    		Action words75 (74.3)


    		Present tense84 (83.2)


    		Short sentences78 (77.2)


    		Limit paragraph size68 (67.3)

    		Usability


    		Images that facilitate learning44 (43.6)


    		Bold colors, no dark backgrounds89 (88.1)


    		Home/Menu pages51 (50.5)


    		Back button37 (36.6)


    		Simple search9 (8.9)


    		Browsing33 (32.7)
    Technology

    		Email32 (31.7)

    		Calendar11 (10.9)

    		Reminders17 (16.8)

    		Maps/GPS4 (4.0)

    		Print3 (3.0)

    		Save8 (7.9)
    Interactivity

    		Personal information15 (14.9)

    		Personal statistics19 (18.8)

    		Expert interaction2 (2.0)

    		Peer support8 (7.9)

    		Connect to an event15 (14.9)

    		Incorporate Audio and Visual31 (30.7)

    		Integrate social media or text messages42 (41.6)
    ‎
    Figure 2. App characteristic percentages on App Store and Google Play: content/goal, primary prevention genetic risk/screening, screening/early detection, and diagnosis (N=101).
    View this figure
    ‎
    Figure 3. App characteristic percentages on App Store and Google Play: management/therapeutics, postcare/end of life, breast cancer care, and research/science (N=101).
    View this figure
    ‎
    Figure 4. App characteristic percentages on App Store and Google Play: plain language and usability (N=101).
    View this figure
    ‎
    Figure 5. App characteristic percentages on App Store and Google Play: technology, interactivity, and approach/theoretical underpinning (N=101).
    View this figure

    Purpose of the Apps

    The analysis included the classification of the apps’ goals by four main categories, according to the messages they advanced: (1) aimed at providing information and education about breast cancer, (2) targeted behavior change related to breast cancer, (3) included messages about fundraising, and (4) aimed at breast cancer advocacy. Most of the apps contained information/education messages (73/101, 72.3%), approximately one-quarter (24/101, 23.9%) targeted behavior change, one-fifth (20/101, 19.8%) aimed at fundraising, and a one-sixth of the apps (14/101, 13.9%) were related to advocacy. More than half of the apps focused on only one of these categories (56/101, 55.4%), 26 (25.7%) on two categories, five (5%) included three categories, and two apps included all categories. Most apps that targeted behavior change also included informational/educational goals (18/101, 75%).

    Breast Cancer Continuum

    Primary Prevention

    Almost one-third of the apps (30/101, 29.7%) presented information about primary prevention of breast cancer, such as information about diet and exercise.

    Screening

    Less than half of the apps in our sample (46/101, 45.5%) presented information about evidence-based methods of breast cancer screening (mammography and breast clinical exam). Of this subsample, 37 apps (80.4%) included information about both mammography and clinical breast exam. Eight apps contained information about breast mammography alone (17.39%), and only one contained information about clinical breast exams (2.17%).

    In all, 53 apps (52.5%) discussed breast self-exam. Additional prediagnosis variables included symptoms of cancer prediagnosis, such as a lump (48/101, 47.5%) and genetic risk for breast cancer (47/101, 46.5%).

    Diagnosis

    Information about breast cancer diagnosis was included in 42 apps (41.6%). Of these apps, 15 (36%) provided information about stages of breast cancer, prognosis, and types of breast cancer tumor together; 10 apps (24%) discussed stages of breast cancer and types of breast cancer tumors together; and two (5%) provided information about stages of cancer as well as prognosis. In addition, 11 (27%) provided information about types of breast cancer tumors only, three (7%) communicated information about stages of breast cancer only, and two (5%) addressed prognosis only.

    Treatment

    Of the 101 apps, 43 (42.6%) discussed various treatment options for breast cancer patients. Of these, 18 (17.8%) provided concurrent information on (1) different treatment options, (2) possible side effects of treatment, and (3) care management of breast cancer; eight (8%) discussed treatment options and side effects; and one (2%) provided information on different treatment options and care management of breast cancer together. Eleven (26%) apps provided information about different treatment options only, and five (12%) discussed care management only.

    Survivorship and End of Life

    Seventeen of 101 apps (16.8%) discussed issues related to survivorship, such as care coordination after completion of therapeutic treatment for cancer, financial burden of cancer, late and long-term effects of breast cancer diagnosis and treatment, or health promotion after a breast cancer diagnosis. Only one of 101 apps (1.0%) discussed end-of-life hospice.

    Research and Scientific-Related Information

    In all, 40 of 101 apps (39.6%) provided biological information about breast cancer, such as the mechanism of tumor development in the breast. Only 24 apps (23.8%) cited scientific research or evidence-based guidelines to support their information. Five apps (5.0%) discussed clinical trials.

    Adherence to IOM Literate Design Principles

    Plain Language

    The median of the composite health literacy score was 5 (mean 5.06, SD 2.00), and only 13 (13%) apps had a composite plain language score of 8 of 8. A majority of the apps used present tense (84/101, 83.2%), active voice (78/101, 77.2%), short sentences (78/101, 77.2%), action words (75/101, 74.3%), short paragraph size (68/101, 67.3%), and personal pronouns such as “you” (60/101, 59.4%). However, fewer than half of the apps primarily used common and easy-to-understand words (44/101, 43.6%) and only 24 (23.8%) defined terms.

    Usability

    The median composite usability composite score was 3 (mean 2.60, SD 1.20). None of the apps contained all six usability items recommended by the IOM. Five apps (5.0%) had a composite usability score of 5 of 6. The most common usability feature was the use of bold colors without dark backgrounds (89/101, 88.1%). In all, 51 (50.5%) apps provided easy access to home/menu pages, 44 (43.6%) used images that facilitated learning, 37 (36.6%) had a back button, 33 (32.7%) were easy to browse, and nine (8.9%) had a simple search option available.

    Graphics and Technological Features

    The most common technological feature was the ability to share content via email through the app (32/101, 31.7%). In addition, eight (7.9%) apps had the option to save documents. Four apps (4.0%) connected users to maps or GPS and three (3.0%) provided users the option to print directly from the apps.

    Interactivity

    Most apps (93/101, 92.1%) did not allow the user to customize information (ie, input weight, height, and other personal measures); only eight (7.9%) offered peer support and two (2.0%) provided an “ask the expert” option.

    Adherence to IOM Plain Language and Usability Guidelines by Content Area and Goals

    There was no statistically significant difference in the composite plain language scores of apps that focused on information/education content (mean 5.10, SD 1.89) and apps that did not (mean 4.96, SD 2.41; t40.34=0.26, P=.80). Similarly, although the composite usability scores of apps containing information/education messages (mean 2.71, SD 1.12) were somewhat higher than other apps (mean 2.32, SD 1.25), these differences were not statistically significant (t99=1.52, P=.13) (see Table 3).

    Table 3. Adherence of apps to literate principles (N=101).
    ContentComposite plain language scoreComposite usability score

    		Mean (SD)t (df)PMean (SD)t (df)P
    Information/education content
    		–0.26 (40.34).13
    		–0.26 (99).77

    		No information/ education content4.96 (2.41)

    		2.32 (1.25)


    		With information/education content5.10 (1.89)

    		2.71 (1.12)

    Behavior change content
    		–2.80 (99).006
    		–0.30 (99).77

    		No behavior change content4.75 (2.00)

    		2.58 (1.21)


    		With behavior change content6.04 (1.85)

    		2.67 (1.05)

    Fundraising content
    		–3.47 (99).001
    		0.23 (99).82

    		No fundraising content4.73 (1.97)

    		2.62 (1.11)


    		With fundraising content6.40 (1.73)

    		2.55 (1.39)

    Advocacy content
    		–2.19 (99).031
    		0.11 (99).91

    		No advocacy content4.89 (2.07)

    		2.61 (1.20)


    		With advocacy content6.14 (1.41)

    		2.57 (0.94)

    Apps
    		0.80 (99).43
    		–2.73 (99).007

    		Free5.13 (2.09)

    		2.47 (1.17)


    		Paid4.69 (1.70)

    		3.31 (0.87)

    Apps aimed at behavior change scored higher on use of plain language (mean 6.04, SD 1.85) than apps that did not aim at behavior change (mean 0.75, SD 2.00) and the relationship was statistically significant (t99=2.80, P=.006). Although these type of apps also ranked slightly higher in usability (mean 2.67, SD 1.05) than the apps that did not include behavior change messages (mean 2.58, SD 1.21), the difference was not significant (t99=0.30, P=.77) (see Table 3).

    The t test analysis also revealed that apps with a fundraising purpose had a higher composite plain language score (mean 6.40, SD 1.73) than those without a fundraising purpose (mean 4.73, SD 1.97) and the relationship was statistically significant (t99=3.47, P=.001). There was no significant difference in usability between apps that targeted fundraising (mean 2.55, SD 1.39) and those that did not (mean 2.62, SD 1.11; t99=–0.23, P=.82) (see Table 3).

    Apps that included advocacy for breast cancer causes scored higher for plain language (mean 6.14, SD 1.41) compared to those that did not advocate for breast cancer causes (mean 4.89, SD 2.07) and the relationship was statistically significant (t99=2.19, P=.03). In contrast, advocacy-related apps (mean 2.57, SD 0.94) and apps that did not include advocacy (mean 2.61, SD 1.20) did not differ in their usability (t99=–1.12, P=.91) (see Table 3).

    Differences Between Free and Paid Apps in Adherence to IOM Guidelines

    Of the 73 apps that had information/education content, 58 (79%) were free and 15 (21%) were paid. Most of the 24 apps that targeted behavior change were free (21/24, 88%), and three (13%) were paid. All 20 (100%) of the apps that aimed at fundraising were free. Of the 14 apps that that included breast cancer advocacy, 12 (86%) were free, and two (14%) were paid (see Table 3).

    Free apps (mean 5.13, SD 2.09) did not differ significantly from paid apps in use of plain language (mean 4.69, SD 1.70; t99=–0.80, P=.43). In contrast, paid apps scored higher on usability (mean 3.31, SD 0.87) than free apps (mean 2.47, SD 1.17). The difference was statistically significant (t99=2.73, P=.007) (see Table 3).

    IOM Guidelines and User Ratings

    Pearson correlations and t tests were used to examine the relationship between how well apps followed the IOM guidelines and how highly users rated those apps. Approximately half (49/101) of the apps in the sample were rated by users. There was a significant positive correlation between apps’ user ratings and their composite scores on the health literacy scale (r=.33, P=.02).

    Average ratings were significantly higher for apps that used action words (mean 4.26, SD 1.07) than for apps that did not (mean 3.42, SD 1.52; t47=–2.20, P=.03). Ratings were also higher for apps that used the present tense (mean 4.27, SD 1.03) than for those that did not (mean 3.08, SD 1.63; t12.39=–2.28, P=.04).

    There was no significant correlation between an app’s user rating and its composite usability score (r=.02, P=.85).


    Principal Findings

    This study examined the availability of breast cancer-related apps, their purpose, cancer continuum-related content, adherence to literate principles design, price, and user ratings. At the time of data collection, 101 apps focusing on breast cancer were available to the public. The majority of these apps were available on Android. The proportion of Apple-only apps in the sample represented their respective share of the cellular market of 28% at the time of data collection [49], albeit not the increased likelihood of iPhone users to download apps [50]. This distribution of apps documented in this study demonstrates increasing efforts from developers to provide apps for both Android and iPhone platforms.

    Although apps often have multiple purposes, the majority are designed to provide information and education. Consistent with past studies [14], these findings reveal the limited potential of the current apps available to advance breast cancer-related behavior change. Research has shown that information is important yet insufficient in changing multifaceted health behaviors [51]. The high number of apps that included information/educational content without clear guidelines for behavior change suggests limited utility of currently available apps in behavior change, despite the relative advantage of mHealth in providing interactive features that can support such change. Moreover, the content of most apps does not support evidence-based, comprehensive breast cancer-related behavior change in specific areas. These findings align with past research on cancer apps that identified few evidence-based preventive messages [14]. For instance, although research and consequently clinical guidelines in North America in the past decade concluded that breast self-examination is an ineffective and often harmful screening strategy [52,53], this strategy was featured in more apps compared to the evidence-based strategies of mammography and clinical breast exams. Involving medical professionals in design of apps [22] may improve the quality of the information they provide.

    The findings also indicate that provision of information in support of treatment-related decision making emerges as an area of need. Less than half of the apps that provided information on treatment included information about possible side effects and of treatment options. This deficiency might be explained by the reluctance of developers to include medical information due to paucity of clinical expertise involvement in development of mHealth [50]. However, extant literature documented the importance of such information for women with breast cancer [54], including availability of relatively easy-to-use decision tools [55].

    The analysis of the content of the apps on the cancer continuum reveals that, in contrast to primary breast cancer prevention, screening, and treatment, only a few apps focused on survivorship and only one included information about hospice care. No apps covered other aspects of end-of-life decisions and care. It is possible that information and support on end-of-life decisions and care are available on apps that are not breast cancer-specific (and consequently in apps that were not included in this sample), past research on cancer-related apps did not document such focus [56]. Therefore, these findings lend support to the need for apps that would provide evidence-based information and support behavior change and decision making following breast cancer diagnosis, with extreme need for apps on end-of-life decisions and care.

    The analysis further underscores that greater adherence to literate design strategies continues to be a pressing need in breast cancer app development. Adherence to most usability design standards was low. It is possible that this low adherence relates to lack of experience or training of developers working on this relatively new platform. For instance, the literacy design principle that was most closely adhered to included use of colors, which is consistent with design of websites. In contrast, features that are arguably more significant in-app design, such as an easy browse and use of images, were not frequently included in the apps.

    Similarly, the findings underscore the importance of greater attention to using plain language principles in the design of breast cancer apps. Notably, of the plain language characteristics, text level was still too high in the vast majority of apps, which demonstrates that mHealth developers, like developers of print information [57] and of Web-based information [58], are not effective in bridging the literacy divide using principles such as defining concepts. Therefore, it is evident that the need for more appropriate plain language materials persists. However, behavioral change, advocacy, and fundraising apps demonstrated higher adherence to plain language principles. It is possible that these differences indicate greater degree of professionalism of these apps’ developers.

    Consistent with past studies that examined diabetes-related apps [44], paid apps were more likely than free apps to adhere to literacy guidelines. In this case, paid apps featured usability principles more frequently than free apps. As the vast majority of mobile phone users are reluctant to pay for apps [59], this finding also points at the potential for persistence of disparities between users who are able to use paid apps and those who are restricted to using only free apps. In addition, this study provides additional support to the potential of using reviewer ratings to learn about user experiences. In past research, user ratings were correlated with professional quality ratings of apps [47], but in this study they were correlated with apps’ adherence to plain language principles, thus lending further empirical support to the importance of plain language. To our knowledge, this is the first study to document such an association. In contrast, user ratings were not related to usability. Future studies should explore users’ expectations from apps’ usability in the context of breast cancer.

    This study contributes to research on the use of mHealth to advance breast cancer-related education and behavior change in a few ways. First, this is the first study to focus solely on breast cancer apps. In view of the unique information, education, treatment, and support needs before and following breast cancer diagnosis [60], this focus can advance understanding on the degree to which these apps have the potential to meet these needs. In addition, past studies that examined cancer apps were limited to analyzing only iPhone apps [15], apps’ descriptions in the App Store [14], or reviews of the literature reporting on cancer-related mHealth interventions [16]. By analyzing relevant, working, uploaded apps available on both Android and iPhone platforms, this study provides a more comprehensive analysis of availability to consumers. Moreover, past studies did not examine design of cancer-related apps, including adherence to literacy design principles, and did not focus on breast cancer, whereas this study provides important insights on implementation of literate design strategies.

    Limitations

    As in any research project, the methodologies utilized in this study hold inherent limitations. Specifically, systematic content analyses are helpful in providing an overview on the content available to users and its adherence to scholarly and professional standards, but are limited in their ability to shed light on users’ experiences. Moreover, previous researchers noted that content analysis of mHealth cannot link user information to app use [46]. In addition, information about the sources of the apps was not available; therefore, analysis of the relationship between app-related factors such as release dates, content source, organizational affiliation, or country of origin was not possible. Similarly, because we included only apps that focused on cancer, we did not examine other apps that might be used for cancer prevention purposes or that people might use to manage symptoms after diagnosis with cancer or survivorship and end of life. Finally, this study was conducted in the United States and, therefore, does not demonstrate availability of breast cancer-related apps in other markets or in languages other than English.

    Conclusions

    Despite exciting potential for consumer engagement along the cancer continuum, availability of evidence-based breast cancer information and integration of literate design strategies to mHealth users is limited. This current state reveals that mHealth has not met its potential in engaging consumers with evidence-based information and design necessary to reduce preventable breast cancer burden and its associated disparities in health outcomes. Specifically, breast cancer-specific apps represent a limited spectrum on the cancer continuum. Therefore, this study is important in supporting the need for better-designed breast cancer apps that would adhere to evidence-based as well as to plain language and usability standards, with an extreme need for apps that focus on information necessary for medical decision making, most notably side effects, survivorship, and end of life.

    As a systematic review, the goal of this study was to provide an overview of availability of breast cancer apps and their adherence to evidence-based content and design principles. Such systematic analyses are time consuming and cannot be performed by users. Further, the characteristics of such users at this point are unknown and are likely very diverse, including cancer-free individuals, cancer patients, and cancer survivors, because different apps target women at different stages on the cancer continuum. Future studies should apply additional, user-centered research methods, including surveys and community-based studies to learn about users’ experiences using apps along the breast cancer continuum.

    Acknowledgments

    Research reported in this publication was supported by grant # IRG-14-187-19 from the American Cancer Society. This research was also supported in part by the following: Washington University Center for Diabetes Translation Research, supported under the National Institute of Diabetes and Digestive and Kidney Disorders, P30DK092950 and National Cancer Institutes of the National Institutes of Health under award number R25CA171994. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

    Conflicts of Interest

    None declared.

    1. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 2015 Mar 01;136(5):E359-E386 [FREE Full text] [CrossRef] [Medline]
    2. Coughlin SS, Ekwueme DU. Breast cancer as a global health concern. Cancer Epidemiol 2009 Nov;33(5):315-318. [CrossRef] [Medline]
    3. Benitez G, Desai J, Schroeder E, Nichols G, Segal J, Karter A, et al. PS1-40: Preventable major cardiovascular events due to uncontrolled glucose, blood pressure, and lipids or active smoking in adults with diabetes with and without cardiovascular disease. Clinical Medicine & Research 2014 Oct 28;12(1-2):81-82. [CrossRef]
    4. Liu P, Wang J, Keating NL. Expected years of life lost for six potentially preventable cancers in the United States. Prev Med 2013 May;56(5):309-313. [CrossRef] [Medline]
    5. Bray F, McCarron P, Parkin DM. The changing global patterns of female breast cancer incidence and mortality. Breast Cancer Res 2004;6(6):229-239 [FREE Full text] [CrossRef] [Medline]
    6. López-Gómez M, Malmierca E, de Górgolas M, Casado E. Cancer in developing countries: the next most preventable pandemic. The global problem of cancer. Crit Rev Oncol Hematol 2013 Oct;88(1):117-122. [CrossRef] [Medline]
    7. Youlden D, Cramb SM, Dunn NA, Muller JM, Pyke CM, Baade PD. The descriptive epidemiology of female breast cancer: an international comparison of screening, incidence, survival and mortality. Cancer Epidemiol 2012 Jun;36(3):237-248. [CrossRef] [Medline]
    8. Rainie L, Poushter J. Pew Research Center. 2014 Feb 13. Emerging nations catching up to US on technology adoption, especially mobile and social media use   URL: http:/​/www.​pewresearch.org/​fact-tank/​2014/​02/​13/​emerging-nations-catching-up-to-u-s-on-technology-adoption-especially-mobile-and-social-media-use/​ [accessed 2017-02-19] [WebCite Cache]
    9. Lopez MH, Gonzalez-Barrera A, Patten E. Pew Research Center. 2013 Mar 07. Closing the digital divide: Latinos and technology adoption   URL: http://www.pewhispanic.org/2013/03/07/closing-the-digital-divide-latinos-and-technology-adoption/ [accessed 2017-02-19] [WebCite Cache]
    10. Mechael PN. The case for mHealth in developing countries. innovations 2009;4(1):103-118.
    11. Boulos MN, Wheeler S, Tavares C, Jones R. How smartphones are changing the face of mobile and participatory healthcare: an overview, with example from eCAALYX. Biomed Eng Online 2011 Apr 05;10:24 [FREE Full text] [CrossRef] [Medline]
    12. mHealth: New Horizons for Health through Mobile Technologies: Second Global Survey on eHealth. Geneva: World Health Organization; 2011.   URL: http://www.who.int/goe/publications/goe_mhealth_web.pdf [accessed 2017-02-19] [WebCite Cache]
    13. Duggan M. Pew Research Center. 2013 Sep 09. Cell phone activities 2013   URL: http://www.pewinternet.org/2013/09/19/cell-phone-activities-2013/ [accessed 2017-02-19] [WebCite Cache]
    14. Bender JL, Yue RY, To MJ, Deacken L, Jadad AR. A lot of action, but not in the right direction: systematic review and content analysis of smartphone applications for the prevention, detection, and management of cancer. J Med Internet Res 2013 Dec 23;15(12):e287 [FREE Full text] [CrossRef] [Medline]
    15. Pandey A, Hasan S, Dubey D, Sarangi S. Smartphone apps as a source of cancer information: changing trends in health information-seeking behavior. J Cancer Educ 2013 Mar;28(1):138-142. [CrossRef] [Medline]
    16. Davis SW, Oakley-Girvan I. mHealth education applications along the cancer continuum. J Cancer Educ 2015 Jun;30(2):388-394. [CrossRef] [Medline]
    17. Eskandar H, Land MA, Pujari S. Cancer Control. 2015. Mobile technology in cancer control for emerging health systems: digital divide or digital provide?   URL: http://www.cancercontrol.info/wp-content/uploads/2015/07/65-70-Robinson.pdf [accessed 2017-02-07] [WebCite Cache]
    18. Schnall R, Mosley JP, Iribarren SJ, Bakken S, Carballo-Diéguez A, Brown III W. Comparison of a user-centered design, self-management app to existing mHealth apps for persons living with HIV. JMIR Mhealth Uhealth 2015 Sep 18;3(3):e91 [FREE Full text] [CrossRef] [Medline]
    19. Zhang C, Zhang X, Halstead-Nussloch R. Faculty Publications. 2014. Assessment metrics, challenges, and strategies for mobile health apps   URL: http://digitalcommons.kennesaw.edu/facpubs/3617/ [accessed 2017-02-19] [WebCite Cache]
    20. Bailey SC, Belter LT, Pandit AU, Carpenter DM, Carlos E, Wolf MS. The availability, functionality, and quality of mobile applications supporting medication self-management. J Am Med Inform Assoc 2014;21(3):542-546 [FREE Full text] [CrossRef] [Medline]
    21. Derbyshire E, Dancey D. Smartphone medical applications for women's health: what is the evidence-base and feedback? Int J Telemed Appl 2013;2013:782074 [FREE Full text] [CrossRef] [Medline]
    22. Mobasheri MH, Johnston M, King D, Leff D, Thiruchelvam P, Darzi A. Smartphone breast applications - what's the evidence? Breast 2014 Oct;23(5):683-689. [CrossRef] [Medline]
    23. Ferrero N, Morrell DS, Burkhart CN. Skin scan: a demonstration of the need for FDA regulation of medical apps on iPhone. J Am Acad Dermatol 2013 Mar;68(3):515-516. [CrossRef] [Medline]
    24. Broderick J, Devine T, Langhans E, Lemerise AJ, Lier S, Harris L. National Academy of Medicine. 2014 Jan 28. Designing health literate mobile apps   URL: https://nam.edu/perspectives-2014-designing-health-literate-mobile-apps/ [accessed 2017-02-19] [WebCite Cache]
    25. Free C. The effectiveness of mobile-health technology-based health behaviour change or disease management interventions for health care consumers: a systematic review. PLoS med 2013;10(1):a. [CrossRef]
    26. Spradley JP, McCurdy DW. Anthropology: The Cultural Perspective. Hoboken, NJ: John Wiley & Sons; 1980.
    27. Spradley JP. Participant Observation. Long Grove, IL: Waveland Press; 2016.
    28. Astin JA. Why patients use alternative medicine: results of a national study. JAMA 1998 May 20;279(19):1548-1553. [Medline]
    29. Heaton J. Reworking Qualitative Data. Thousand Oaks, CA: SAGE Publications; 2004.
    30. Fu MR, Axelrod D, Guth AA, Rampertaap K, El-Shammaa N, Hiotis K, et al. mHealth self-care interventions: managing symptoms following breast cancer treatment. Mhealth 2016 Jul;2 [FREE Full text] [CrossRef] [Medline]
    31. Mackert M, Mabry-Flynn A, Champlin S, Donovan EE, Pounders K. Health literacy and health information technology adoption: the potential for a new digital divide. J Med Internet Res 2016 Oct 04;18(10):e264 [FREE Full text] [CrossRef] [Medline]
    32. Demark-Wahnefried W, Pinto BM, Gritz ER. Promoting health and physical function among cancer survivors: potential for prevention and questions that remain. J Clin Oncol 2006 Nov 10;24(32):5125-5131. [CrossRef] [Medline]
    33. McCarroll ML, Armbruster S, Pohle-Krauza RJ, Lyzen AM, Min S, Nash DW, von Gruenigen Vivian E. Feasibility of a lifestyle intervention for overweight/obese endometrial and breast cancer survivors using an interactive mobile application. Gynecol Oncol 2015 Jun;137(3):508-515. [CrossRef] [Medline]
    34. Goode A, Lawler SP, Brakenridge CL, Reeves MM, Eakin EG. Telephone, print, and Web-based interventions for physical activity, diet, and weight control among cancer survivors: a systematic review. J Cancer Surviv 2015 Dec;9(4):660-682. [CrossRef] [Medline]
    35. Lyons E, Baranowski T, Basen-Engquist KM, Lewis ZH, Swartz MC, Jennings K, et al. Testing the effects of narrative and play on physical activity among breast cancer survivors using mobile apps: study protocol for a randomized controlled trial. BMC Cancer 2016 Mar 09;16:202 [FREE Full text] [CrossRef] [Medline]
    36. Hargittai E. First Monday. 2002 Apr. Second-level digital divide: differences in people's online skills   URL: http://firstmonday.org/article/view/942/864 [accessed 2017-02-19] [WebCite Cache]
    37. Norman C, Skinner HA. eHealth literacy: essential skills for consumer health in a networked world. J Med Internet Res 2006 Jun 16;8(2):e9 [FREE Full text] [CrossRef] [Medline]
    38. Peerson A, Saunders M. Health literacy revisited: what do we mean and why does it matter? Health Promot Int 2009 Sep;24(3):285-296. [CrossRef] [Medline]
    39. Davis T, Williams MV, Marin E, Parker RM, Glass J. Health literacy and cancer communication. CA Cancer J Clin 2002;52(3):134-149 [FREE Full text] [Medline]
    40. Neter E, Brainin E. eHealth literacy: extending the digital divide to the realm of health information. J Med Internet Res 2012 Jan 27;14(1):e19 [FREE Full text] [CrossRef] [Medline]
    41. Rios G. eHealth literacy and older adults. Top Geriatr Rehabil 2013;29(2):116-125. [CrossRef]
    42. Ginossar T. Predictors of online cancer prevention information seeking among patients and caregivers across the digital divide: a cross-sectional, correlational study. JMIR Cancer 2016 Mar 09;2(1):e2. [CrossRef]
    43. Ginossar T. Disparities and antecedents to cancer prevention information seeking among cancer patients and caregivers attending a Minority-Serving Cancer Center. J Commun Healthcare 2014 Jul 09;7(2):93-105. [CrossRef]
    44. Caburnay CA, Graff K, Harris JK, McQueen A, Smith M, Fairchild M, et al. Evaluating diabetes mobile applications for health literate designs and functionality. Prevent Chron Dis 2014:12. [CrossRef]
    45. Holzemer WL, Human S, Arudo J, Rosa ME, Hamilton MJ, Corless I, et al. Exploring HIV stigma and quality of life for persons living with HIV infection. J Assoc Nurses AIDS Care 2009;20(3):161-168. [CrossRef] [Medline]
    46. Molina Y, Ramirez-Valles J. HIV/AIDS stigma: measurement and relationships to psycho-behavioral factors in Latino gay/bisexual men and transgender women. AIDS Care 2013;25(12):1559-1568 [FREE Full text] [CrossRef] [Medline]
    47. Stoyanov S, Hides L, Kavanagh DJ, Zelenko O, Tjondronegoro D, Mani M. Mobile app rating scale: a new tool for assessing the quality of health mobile apps. JMIR Mhealth Uhealth 2015;3(1):a. [CrossRef]
    48. Abroms L, Padmanabhan N, Thaweethai L, Phillips T. iPhone apps for smoking cessation: a content analysis. Am J Prev Med 2011 Mar;40(3):279-285 [FREE Full text] [CrossRef] [Medline]
    49. Gant LM, Nagda BA, Brabson HV, Jayaratne S, Chess WA, Singh A. Effects of social support and undermining on African American workers' perceptions of coworker and supervisor relationships and psychological well-being. Soc Work 1993 Mar;38(2):158-164. [Medline]
    50. Santen SA, Deiorio NM, Gruppen LD. Medical education research in the context of translational science. Acad Emerg Med 2012 Dec;19(12):1323-1327 [FREE Full text] [CrossRef] [Medline]
    51. Ng T, F DC. Age and innovation-related behavior: the joint moderating effects of supervisor undermining and proactive personality. J Organiz Behav 2012 May 23;34(5):583-606. [CrossRef]
    52. Wohl AR, Galvan FH, Carlos J, Myers HF, Garland W, Witt MD, et al. A comparison of MSM stigma, HIV stigma and depression in HIV-positive Latino and African American men who have sex with men (MSM). AIDS Behav 2013 May;17(4):1454-1464. [CrossRef] [Medline]
    53. Freeman E. Understanding HIV-related stigma in older age in rural Malawi. Soc Sci Med 2016 Sep;164:35-43. [CrossRef] [Medline]
    54. Elwyn G, Lloyd A, Joseph-Williams N, Cording E, Thomson R, Durand M, et al. Option grids: shared decision making made easier. Patient Educ Couns 2013 Feb;90(2):207-212. [CrossRef] [Medline]
    55. Charles C, Gafni A, Whelan T. Decision-making in the physician-patient encounter: revisiting the shared treatment decision-making model. Soc Sci Med 1999 Sep;49(5):651-661. [Medline]
    56. LaBresh K, Ariza AJ, Lazorick S, Furberg RD, Whetstone L, Hobbs C, et al. Adoption of cardiovascular risk reduction guidelines: a cluster-randomized trial. Pediatrics 2014 Sep;134(3):e732-e738 [FREE Full text] [CrossRef] [Medline]
    57. McGaghie W. Medical education research as translational science. Sci Transl Med 2010;2(19):8-19. [CrossRef]
    58. Price D, Wagner DP, Krane NK, Rougas SC, Lowitt NR, Offodile RS, et al. What are the implications of implementation science for medical education? Med Educ Online 2015;20:27003 [FREE Full text] [Medline]
    59. Zhong N. Google play is not a long tail market: an empirical analysis of app adoption on the Google play app market. In: Proceedings of the 28th Annual ACM Symposium on Applied Computing. 2013 Presented at: SAC '13 28th Annual ACM Symposium on Applied Computing; Mar 18-22, 2013; Coimbra, Portugal p. 499-504.
    60. Ashing-Giwa K, Padilla G, Tejero J, Kraemer J, Wright K, Coscarelli A, et al. Understanding the breast cancer experience of women: a qualitative study of African American, Asian American, Latina and Caucasian cancer survivors. Psychooncology 2004 Jun;13(6):408-428 [FREE Full text] [CrossRef] [Medline]

    ‎
    IOM: Institute of Medicine

    Edited by G Eysenbach; submitted 29.11.16; peer-reviewed by TZ Hayat, H Enwald, A Young; comments to author 05.01.17; revised version received 13.01.17; accepted 29.01.17; published 13.03.17

    Copyright

    ©Tamar Ginossar, Sayyed Fawad Ali Shah, Andrew J West, Joshua M Bentley, Charlene A Caburnay, Matthew W Kreuter, Anita Y Kinney. Originally published in JMIR Mhealth and Uhealth (http://mhealth.jmir.org), 13.03.2017.

    This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in JMIR mhealth and uhealth, is properly cited. The complete bibliographic information, a link to the original publication on http://mhealth.jmir.org/, as well as this copyright and license information must be included.